Africa Eastern and Southern vs Sweden: Access to anti-retroviral drugs, male
Africa Eastern and Southern
80.8%
in 2024
Sweden
95.0%
in 2022
Africa Eastern and Southern rank
3rd
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Africa Eastern and Southern
- Sweden
How they compare
Sweden currently reports 95.0% against 80.8% in Africa Eastern and Southern, a difference of 14.2%.
That makes Sweden's figure about 1.2 times Africa Eastern and Southern's.
Across all 23 years both countries report, Sweden has been ahead every year.
Africa Eastern and Southern ranks 3rd and Sweden ranks 4th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa Eastern and Southern | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.9% | 53.7% | 47.8% | Sweden |
| 2010s | 45.4% | 92.5% | 47.1% | Sweden |
| 2020s | 73.0% | 95.3% | 22.4% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Africa Eastern and Southern or Sweden?
- Sweden, at 95.0% against 80.8% in Africa Eastern and Southern as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Africa Eastern and Southern and Sweden?
- 14.2%, with Sweden ahead.
- How many years of comparable data are there for Africa Eastern and Southern and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Africa Eastern and Southern and Sweden rank globally for access to anti-retroviral drugs, male?
- Africa Eastern and Southern ranks 3rd and Sweden ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.